SNHG20 and neoplasm: Previous research showed that SNHG20 is highly expressed in NSCLC and can interact with the enhancer of histone methyltransferase 2 to drive P21 expression, thereby inhibiting apoptosis and promoting tumor proliferation and invasion (Chen et al., 2017), suggesting that SNHG20 is closely associated with NSCLC.